Pfizer vaccine is effective against omicron variant after “three doses”
Berlin, December 8, 2021Updated on 12/08/2021 07:57 am The coronavirus vaccine developed by the Pfizer and BioNTech laboratories is “effective” against the omicron variant after
Berlin, December 8, 2021Updated on 12/08/2021 07:57 am The coronavirus vaccine developed by the Pfizer and BioNTech laboratories is “effective” against the omicron variant after
Lima, December 7, 2021Updated on 07/12/2021 05:31 pm The CEO of the pharmaceutical company Pfizer, Albert Bourla, assured this Tuesday that the symptoms caused by
The third booster dose applied by the Dominican Republic with Pfizer serum, combined with two doses of the vaccine against COVID-19 of Sinovac, is “safe”
Lima, December 3, 2021Updated on 03/12/2021 09:54 am Booster doses of current COVID-19 vaccines offer different protection based on different brands, although overall immunity improves
The BioNTech / Pfizer vaccine in its corresponding dosage for children between 5 and 11 years of age will be distributed to the member states
In a period of 100 days, a vaccine could be developed against the new omicron variant of COVID-19, assured the president and director of Pfizer
New York, November 29, 2021Updated on 11/29/2021 11:31 am Pfizer has already started work on a new version of its vaccine against COVID-19 aimed more
The main manufacturers of vaccines against COVID-19 in the West, including the Americans Pfizer, Moderna and Johnson & Johnson, reported this Friday that they are
The German laboratory BioNTech said on Friday that it was urgently studying the efficacy of the vaccine against COVID-19 which he developed with Pfizer to
A study finds a gradual increase in the risk of infection by COVID-19 beginning 90 days after receiving a second dose of the Pfizer /
Lima, November 25, 2021Updated on 11/25/2021 09:33 am The European Medicines Agency (EMA) supported on Thursday the extension of the current European license of the
The authorities canadians approved this Friday the use of Pfizer’s vaccine against covid-19 for children between 5 and 11 years old. The Ministry of Health
The United States on Friday extended authorization for booster vaccines against COVID-19 to all people over 18 years of age, six months after completing their
This Friday, USA extended the authorization of the reinforcements of the vaccine against him COVID-19 to all people over 18 years of age, six months
Lima, November 16, 2021Updated on 11/16/2021 03:30 pm Pfizer today applied for emergency use authorization from the United States Food and Drug Administration (FDA) for
Pfizer signed a voluntary license agreement that must allow access to its anti-drug pill. COVID-19 beyond the rich countries once it has been authorized, the
Around the same time as the pandemic of the COVID-19, scientists were able, in record time, to develop various types of vaccines to prevent severe
Lima, November 5, 2021Updated on 05/11/2021 07:34 am The Pfizer laboratory announced this Friday that a clinical trial on its pill against COVID-19 – the
A subcontractor to Pfizer Pharmaceuticals, charged with conducting a small portion of the clinical trials of its vaccine against COVID-19, made several mistakes during testing,
The US Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech vaccine against COVID-19 for children ages 5 to 11 on Friday.